Topic:

April 2024

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Anifrolumab (Saphnelo) listed in SK

Read

Belimumab (Benlysta) listed in AB, NL & NIHB

Read

Belimumab (Benlysta) listed in ON

Read